Management ChangeApr 7, 2026, 08:31 AM
Azenta Announces Departure of Multiomics President Ginger Zhou and Appointment of William "Trey" E. Martin III
AI Summary
Azenta, Inc. announced that Ginger Zhou stepped down as President of the Multiomics business, and William "Trey" E. Martin III was appointed as her replacement, effective April 6, 2026. Zhou will continue in an advisory role through November 2026 with a consulting fee of $103,500, while Martin brings experience as former CEO of Maravai LifeSciences Holdings, Inc., potentially signaling a strategic shift or renewed focus on the Multiomics business.
Key Highlights
- Ginger Zhou stepped down as President of the Multiomics business on April 6, 2026, and will serve as an advisor through November 2026.
- William "Trey" E. Martin III was appointed as the new President of the Multiomics business, effective April 6, 2026.
- Martin previously served as CEO of Maravai LifeSciences Holdings, Inc.